Resources
About Us
Medical Coatings Market by Type (Hydrophilic, Antimicrobial, Drug-eluting, Anti-thrombogenic), Material (Polymer {Fluoropolymers, Parylene, Silicon}, Metal {Silver, Titanium}), Application (Medical Devices, Implants, Equipment) - Global Forecast to 2030
Report ID: MRHC - 104769 Pages: 180 Jun-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours Download Free Sample ReportThe Medical Coatings Market is projected to reach $3.32 billion by 2030, at a CAGR of 11.20% from 2024 to 2030. Medical devices, implants, and equipment are highly specialized and require a coating of specific materials. The surface coating of medical devices improves performance and, most importantly, the safety of the devices. The medical implants placed inside the body must be compatible with the human tissue. Medical coatings are required to ensure that the device that comes in contact with human tissues is biocompatible.
The growth of this market is driven by factors such as the rising incidence of healthcare-associated infections (HAIs), growing adoption of minimally invasive surgical procedures, and high demand from the medical devices industry. Furthermore, the growing demand for customized and multifunctional coatings and potential in emerging economies are expected to provide significant growth opportunities for this market.
However, the rising raw material prices and high costs & miniaturization of medical devices are the factors that are expected to hinder the growth of this market. Additionally, factors such as the limitations of certain types of coatings with regards to biocompatibility, lack of standardization, and durability, among others and the risk of coating failure associated with the use of hydrophilic and/or hydrophobic coated medical devices are some of the major challenges for the growth of this market.
Click here to: Get a Free Sample Copy of this report
Hospital-acquired infections (HAIs), also known as nosocomial infections, are diseases acquired in hospitals or healthcare facilities that manifest 48 hours or more after admission or within 30 days of discharge. According to the WHO, out of every 100 hospitalized patients, seven in developed and ten in developing countries acquire at least one healthcare-associated infection. Also, the prevalence of device-associated infections in developing countries is up to 13 times higher than in developed countries.
It is reported that each year around 313 million surgeries are performed globally. According to the WHO, surgical site HAIs are observed frequently, with an incidence rate of 0.5% to 15% out of total surgeries. It has been reported by the Centers for Disease Control and Prevention (CDC) that approximately 27 million surgical procedures are performed in the U.S. each year, with up to 5% of patients acquiring surgical site infections.
Some medical coatings contain antimicrobial agents that prevent the growth of bacteria and other harmful pathogens. They can also be a barrier between the medical device and the patient's body, preventing contamination. Cleaning and disinfecting medical devices are made easier with medical coatings that have smooth and non-porous surfaces. Additionally, biocompatible and non-toxic coatings can reduce adverse reactions in patients, including infections. Lastly, medical coatings that reduce friction can lower the risk of device-related injuries, increasing the risk of infection. By reducing the risk of HAIs, medical coatings can improve patient outcomes and decrease the healthcare costs associated with treating infections.
In 2024, the Hydrophilic Coatings Segment is Expected to Dominate the Medical Coatings Market
Based on type, the hydrophilic coatings market is segmented into hydrophilic coatings, antimicrobial coatings, drug-eluting coatings, anti-thrombogenic coatings and other types. In 2024, the hydrophilic coatings segment is expected to account for the largest share of the medical coatings market. The large market share of this segment is attributed to the high demand for hydrophilic-coated medical devices due to its advantages such as reduced friction, increased lubrication, and high compatibility with blood & other body fluids.
In 2024, the Polymers Segment is Expected to Account for the Largest Share of the Medical Coatings Market
Based on material type, the medical coatings market is segmented into polymers, metals, and other material types. In 2024, the polymers segment is expected to account for the largest share of the medical coatings market. The large market share of this segment can be attributed to the ability of polymers to effectively improve durability and provide corrosion resistance and better biocompatibility. Further, a variety of types of polymers are available for different types of applications, such as fluoropolymer coatings, which have the property to provide dry lubrication, insulation, and non-stick properties.
In 2024, the Medical Devices Segment is Expected to Account for the Largest Share of the Medical Coatings Market
Based on application, the medical coatings market is segmented into medical devices, medical implants, medical equipment & surgical tools, and other applications. In 2024, the medical devices segment is expected to account for the largest share of the medical coatings market. The large market share of this segment is attributed to the increased demand for medical devices such as guidewires, endotracheal tubes, catheters, etc., and the ability of medical coatings to improve patient safety and reduce infections.
Asia-Pacific: The Fastest-growing Market
Asia-Pacific is slated to register the fastest growth rate in the medical coatings market during the forecast period. The high market growth in Asia-Pacific is attributed to the growing medical devices market in the region, increasing number of surgeries, growing hospitalization rates, and rising healthcare expenditure.
Key Players
The report includes a competitive landscape based on an extensive assessment of mode of use, type, application, end user, geographic presence, and the key growth strategies adopted by leading market players in the industry over the past years 2020–2022. The key players profiled in the medical coatings market are Hydromer Inc. (U.S.), Harland Medical Systems, Inc. (U.S.), SurModics, Inc. (U.S.), Koninklijke DSM N.V. (Netherlands), AST Products, Inc. (U.S.), Biocoat Incorporated (U.S.), Precision Coating Company, Inc (U.S.), Medicoat AG (Switzerland), Merit Medical Systems, Inc. (U.S.), and Specialty Coating Systems, Inc. (U.S.).
Scope of the Report:
Medical Coatings Market, by Type
Medical Coatings Market, by Material Type
(Other metals include stainless steel, nitinol, platinum, gold, nickel, and titanium, among others)
(Other material types include acrylic and ceramic, among others)
Medical Coatings Market, by Application
Medical Coatings Market, by Geography
Key questions answered in the report:
The medical coatings market report covers the market sizes & forecasts based on type, material type, application, and geography. The medical coatings market studied in this report involves the value analysis of various segments and sub-segments at the regional and country levels.
The medical coatings market is projected to reach $3.32 billion by 2030, at a CAGR of 11.20% during the forecast period of 2024–2030.
Based on type, the medical coatings market is segmented into hydrophilic coatings, antimicrobial coatings, drug-eluting coatings, anti-thrombogenic coatings and other types. In 2024, the hydrophilic coatings segment is expected to account for the largest share of the medical coatings market due to its benefits, such as higher compatibility with blood, increased lubrication, property of hydrophilic coating to cause minimal resistance, while the device comes in contact with the human tissue or body fluids.
Based on type, the medical coatings market is segmented into polymers, metals, and other material types. In 2024, the polymers segment is expected to account for the largest share of the medical coatings market. The polymers segment is further segmented into fluoropolymers, perylene, silicones, and other polymers. The fluoropolymers segment is expected to hold the largest share of the medical coatings market for polymers due to its advantageous properties, including non-stickiness, non-corrosiveness, and inert nature.
Based on application, the medical coatings market is segmented into medical devices, medical implants, medical equipment & surgical tools, and other applications. In 2024, the medical devices segment is expected to account for the largest share of the medical coatings market due to the increased demand for medical devices, especially in emerging economies, with high requirements for coated medical devices to reduce infections and improve patient safety.
The growth of this market is driven by factors such as the rising incidence of healthcare-associated infections (HAIs), growing adoption of minimally invasive surgical procedures, and high demand from the medical devices industry. Furthermore, the growing demand for customized and multifunctional coatings and potential in emerging economies are expected to provide significant growth opportunities for this market.
The rising raw material prices and high costs and miniaturization of medical devices are the factors that are expected to hinder the growth of this market. Additionally, factors such as the limitations of certain types of coatings with regards to biocompatibility, lack of standardization, and durability, among others, and the risk of coating failure associated with using hydrophilic and/or hydrophobic coated medical devices are some of the major challenges for the growth of this market.
The key players operating in the medical coatings market are Hydromer Inc. (U.S.), Harland Medical Systems, Inc. (U.S.), SurModics, Inc. (U.S.), Koninklijke DSM N.V. (Netherlands), AST Products, Inc. (U.S.), Biocoat Incorporated (U.S.), Precision Coating Company, Inc (U.S.), Medicoat AG (Switzerland), Merit Medical Systems, Inc. (U.S.), and Specialty Coating Systems, Inc. (U.S.).
The Asia-Pacific region is slated to witness the highest growth rate during the forecast period and offer significant growth opportunities for the players operating in this market. The high market growth in Asia-Pacific is attributed to the increasing healthcare expenditure, growing medical devices industry, high hospitalization rates, and rising incidents of hospital-acquired infections.
Published Date: Aug-2024
Published Date: Aug-2024
Published Date: Jan-2023
Published Date: Jun-2024
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates